RIG-I activation is involved in the development of autoimmune diseases such as systemic lupus erythematosus (SLE) [31] and atypical Singleton-Merten Syndrome (SMS) [32,33]. This evidence concerns the gene RIGI and Smith-Magenis syndrome.